Cyfuse Biomedical K.K. (TYO:4892)
Japan · Delayed Price · Currency is JPY 565.00
-4.00 (-0.70%)
Oct 26, 2026, 3:30 PM JST
Cyfuse Biomedical K.K. Market Cap
Cyfuse Biomedical K.K. has a market cap or net worth of 5.63 billion as of October 26, 2026. It is the 32,546th most valuable company in the world and the 2,983rd biggest in Japan. Its market cap has increased by 11.68% in one year.
Market Cap
5.63B
Enterprise Value
3.47B
Revenue
305.00M
Global Rank
Country Rank
#2,983 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 1, 2022, Cyfuse Biomedical K.K.'s market cap has decreased from 13.00B to 5.63B, a decrease of -56.70%. That is a compound annual growth rate of -19.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 5.63B | -0.73% |
| Dec 30, 2025 | 5.67B | 54.23% |
| Dec 30, 2024 | 3.68B | -38.27% |
| Dec 29, 2023 | 5.96B | -37.68% |
| Dec 30, 2022 | 9.56B | -26.49% |
| Dec 1, 2022 | 13.00B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 7.16B |
| Chiome Bioscience | 7.10B |
| ADR Biomedical Holdings | 6.68B |
| MEDINET | 6.24B |
| CellSource | 6.21B |
| TMS Co., Ltd. | 6.03B |
| SUSMED,Inc. | 5.83B |
| Soiken Holdings | 5.68B |